Engineering microbes to power the new industrial and healthcare revolution

SBRC PR
24 Jul 2017 00:15:00.000

A world-leading team of scientists has developed a new and faster way to genetically engineer bacteria called Clostridia that have the potential to revolutionise the energy, food and medical therapeutics industries.

While certain Clostridia have achieved notoriety as the causative agents of diseases such as antibiotic-associated diarrhoea (the superbug Clostridium difficile), or food-borne botulism (Clostridium botulinum), the vast majority are completely harmless and can be used to make the chemicals and fuels society needs from sustainable resources, and even to treat cancer.

Through the use of their proprietary technology based on the genome-editing tool CRISPR-Cas9, scientists at Nottingham’s BBSRC/EPSRC Synthetic Biology Research Centre (SBRC) are able to rapidly alter the genetic make-up of all types of Clostridia tested to date. Alterations include the removal of undesirable traits, such as toxin production or antibiotic resistance, enhancing their anti-tumour potential, or increasing the productivity of chemical and fuel manufacture.
Click here for full story

Story credits

More information is available from Professor Nigel Minton on +44 (0)115 846 6287, nigel.minton@nottingham.ac.uk

Additional resources

No additional resources for this article

Related articles

No related articles

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798
email: pressoffice@nottingham.ac.uk